The Utility of Ablative Radiotherapy in Metastatic Breast Cancer
Julia White, MD, from The Ohio State University Comprehensive Cancer Center, discusses the utility of ablative radiotherapy in metastatic breast cancer.
Clinical Pearls
Julia White, MD, professor, director, Breast Radiation Oncology, vice chair, Clinical Research, The Ohio State University Comprehensive Cancer Center, discusses the utility of ablative radiotherapy in metastatic breast cancer.
- An ablative radiotherapy approach to metastatic regions allows for the avoidance of a surgical procedure.
- Though surgical procedures are typically well tolerated, there are inherent risks associated with anesthesia and complications following surgery.
- Patients must stop systemic therapy in order to undergo surgery. With an ablative radiotherapy approach, there are no treatment interruptions.
Recent Videos
Related Content
Roundtable Roundup: Adjuvant Therapy for HR+, HER2- Breast Cancer
June 17th 2025Article
In separate, live virtual events, William J. Gradishar, MD; and Tiffany A. Traina, MD, discussed multiple scenarios for a patient with hormone receptor–positive, HER2-negative breast cancer to potentially receive hormonal plus endocrine therapy.
Read More
